A detailed history of National Bank Of Canada transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, National Bank Of Canada holds 748 shares of ARCT stock, worth $12,364. This represents 0.0% of its overall portfolio holdings.

Number of Shares
748
Previous 748 -0.0%
Holding current value
$12,364
Previous $17,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$18.08 - $25.38 $940 - $1,319
-52 Reduced 6.5%
748 $17,000
Q2 2024

Aug 02, 2024

BUY
$24.35 - $44.39 $19,480 - $35,512
800 New
800 $19,000
Q1 2022

May 05, 2022

SELL
$17.64 - $39.57 $882 - $1,978
-50 Reduced 41.67%
70 $2,000
Q4 2021

Jan 24, 2022

BUY
$34.2 - $47.56 $4,104 - $5,707
120 New
120 $4,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $439M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.